Abstract

The Superior Health Council (SHC) recommends vaccination with Ixchiq® against chikungunya for individuals aged 12 to 64 traveling to regions with an active outbreak.

Given the current safety concerns, the Superior Health Council (SHC) temporarily suspends vaccination with Ixchiq® in individuals aged 65 and older as a precautionary measure, in line with the EMA recommendation (7th of May 2025).

Vaccination should ideally be administered at least 14 days before departure and is also advised for laboratory personnel handling the virus. People with a confirmed past infection do not need vaccination.

The SHC will update its recommendations as new data or vaccines become available.

  • Recommendation
  • Europe
  • Belgium
  • Chikungunya